Research for a Future
without Diabetes

„Research for a future without diabetes – this is the mission of the DZD that inspires and unites us.“

Prof. Martin Hrabě de Angelis, DZD board member

Research for a Future
without Diabetes

„The Germany-wide cooperation in the DZD ensures that multicenter studies can be carried out with the required number of participants.“

Prof. Michael Roden, DZD board member

Research for a Future
without Diabetes

„The DZD places particular importance on the fast transfer of lab results to patient care.“

Prof. Michele Solimena, DZD speaker

„The special feature of research at the DZD is the close interdisciplinary cooperation between different disciplines.“

Prof. Annette Schuermann, DZDSpeaker

DZD - German Center
for Diabetes Research

Press Releases 2018

Neuherberg, 02.02.2018

Type 2 Diabetes: the Costs of Treating Complications

Scientists at the Helmholtz Zentrum München have examined health insurance data of more than 300,000 people with diabetes in Germany. Their report, published in the medical journal ‘Diabetes Care’, breaks down the costs involved in treating various complications of the disease. The Helmholtz authors are members of the German Center for Diabetes Research (DZD).


Tübingen/Neuherberg, 29.01.2018

Prostate Cancer: Poor Prognosis in Men with Diabetes

Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher. Researchers of the German Center for Diabetes Research (DZD) from Tübingen and experts of Helmholtz Zentrum München and the Urology Department of Tübingen University Hospital were able to show that in the affected individuals the androgen receptor and the mitogenic forms of the insulin receptor were more strongly expressed. This could explain why patients with diabetes have a poorer prognosis for prostate cancer. The current results were published in the journals "Molecular Metabolism" and "Endocrine Related Cancer".


Düsseldorf, 19.01.2018

Maren Carstensen-Kirberg Receives Award from Dr. Eickelberg Foundation for Biomarker Research

Dr. Maren Carstensen-Kirberg, research associate at the German Diabetes Center (DDZ), has been awarded the Dr. Eickelberg Foundation Prize 2017 for her research into biomarkers. An interdisciplinary team received the project grant for their project investigating the importance of the pro-inflammatory effect of the biomarker omentin on cells in adipose tissue.


Düsseldorf, 02.01.2018

Donation to Promote Diabetes Prevention

The Glomm Bakery and Pastry Shop and Fortuna Düsseldorf Clubhaus Bar95 support the SMS initiative.


Neuherberg, 04.01.2018

Autoimmune Reaction Successfully Halted in Early Stage Islet Autoimmunity

Scientists at Helmholtz Zentrum München have discovered a mechanism that amplifies the autoimmune reaction in an early stage of pancreatic islet autoimmunity prior to the progression to clinical type 1 diabetes. If the researchers blocked the corresponding molecules, the immune system was significantly less active. The study was conducted under the auspices of the German Center for Diabetes Research (DZD) and was published in the journal ‘Science Translational Medicine’.


Press contact

Birgit Niesing

+49 (0)89 3187-3971